Bank Of America Corp Pro Phase Labs, Inc. Transaction History
Bank Of America Corp
- $1.21 Trillion
- Q1 2025
A detailed history of Bank Of America Corp transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 27,055 shares of PRPH stock, worth $11,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,055
Previous 36,719
26.32%
Holding current value
$11,904
Previous $27,000
62.96%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PRPH
# of Institutions
36Shares Held
4.74MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT1.53MShares$671,2680.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA408KShares$179,6370.0% of portfolio
-
Four World Capital Management LLC New York, NY377KShares$165,6930.1% of portfolio
-
Quinn Opportunity Partners LLC Charlottesville, VA318KShares$139,9750.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny300KShares$131,9160.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $7.05M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...